INTRODUCTION {#cesec10}
============

The use of bone transplants in orthopedic surgery and dentistry has become indispensable in many procedures, including revisions of total hip (RTHA) and knee arthroplasty (RTKA)[@bib1], [@bib2], [@bib3]. Despite its great power of repair, bone tissue does not always respond appropriately when affected by extensive osteolysis[@bib4]. In these cases, which are highly prevalent in orthopedics, high quality bone substitutes or other biomaterials that can fill and restore these gaps need to be sought[@bib4]. A key factor related to the quality of a graft as a bone substitute is the process of bone formation triggered in the host[@bib5]. The biological events responsible for osseointegration are osteogenesis, osteoinduction, and osteoconduction[@bib4]. A biopsy is the gold standard method to determine the phenomena occurring in the graft, and radiographic studies provide only a macroscopic view of what happens microscopically.

Different types of bone grafts are currently available for orthopedic reconstruction: autologous, homologous and heterologous -- xenogenic --, and may be sterilized and preserved by freezing or lyophilization, among other means[@bib5], [@bib6], [@bib7], [@bib8], [@bib9]. From the point of view of integration, the autograft is considered the ideal and preferred replacement; however, limitations as the quantity available and the risk of complications -- local and systemic, ranging from 21% to 49% -- are inherent in the intervention needed for its withdrawal, restricting its applicability[@bib1], [@bib10], [@bib11]. The frozen allogenic graft is widely used in RTHA, but is not always available, and despite strict controls, poses risk of transmission of infectious diseases and tumors[@bib6], [@bib12], [@bib13], [@bib14]. Heterologous grafts, specifically lyophilized bovine graft (LBG), are an option that has been used in several medical areas, due to being easily obtainable, highly available and being highly similar to the human bone[@bib6]. To decrease the antigenicity and preserving only the protein-mineral matrix, the LBG is washed, degreased, and decellularized, and is then dehydrated. The bovine bone -- raw material for obtaining the proposed graft -- has a chemical composition, porosity, size, shape, and biological behavior similar to that of human bone, providing the support structure and osteoconduction, besides providing high content of calcium and phosphorus, which are essential for the neoformation of bone tissue[@bib4]. Several studies show this type of grafting experiment in animals[@bib15], [@bib16], [@bib17], [@bib18], [@bib19]; however, only one performed histological analysis in humans[@bib20]. The results of animal studies are hardly applicable in humans because of existing physical and biological differences between them. Thus, studies that will elucidate the behavior of xenografts in humans are of great value.

The fundamental hypothesis of the study, related to the use of the LBG produced according to the protocol developed by the main author, is its applicability as a temporary structural support that allows osteoconduction and integration of the newly formed bone in deficient areas, promoting satisfactory filling. Our study is justified since there is little detailed information on the subject and the available data are controversial[@bib17], [@bib18], [@bib19], [@bib20], [@bib21], [@bib22].

This study aims to analyze the histological behavior of this LBG specifically, in humans, during 49 (six to 115) months by measuring the ratio between the graft and bone formation in relation to total mineralized area.

MATERIALS AND METHODS {#cesec20}
=====================

The study design is a series of cases that analyzed the histological findings of the LBG produced according to the protocol developed by the main author[@bib11], [@bib12], in partnership with Baumer (Mogi Mirim, São Paulo, Brazil) and the Hospital de Clínicas Porto Alegre (HCPA), in human models. The protocol used for this production was based on a modification of that of Kakiuchi et al[@bib23] of Osaka University, Japan, published in 1996. After the modifications, the LBG maintained the chemical (protein-mineral composition) and structural nature of the raw material virtually unchanged, fostering a product that was suitable for its intended use, therefore, with applicability in humans[@bib13].

The group studied consists of 12 patients, totaling 13 samples, collected from July 2000 to January 2011 (mean of 49 months). The LBG was used alone as a graft in cases with significant bone defects -- subjectively evaluated by the orthopedic team -- resulting from an acute or chronic pre-existing pathology. The inclusion criterion was the need to use LBG in primary surgeries or reoperations that the patients may have undergone. Most of these were in good clinical condition and had no pathology that contraindicated surgery; however, it is worth clarifying: in the patient JARS, due to the large volume of LBG used in the first surgery, it was possible to collect two biopsies from different areas to be counted as two cases; patient SG showed signs of infection in the first surgery, and the RTHA was performed in the same procedure as grafting.

The biopsies were collected at the time of reintervention (due to causes unrelated to grafting).

It is important to emphasize that in no way was any procedure performed with the sole purpose of removing bone fragments for analysis of the behavior of the graft. The follow-up period was estimated from the primary intervention until the time of biopsy. Seven of these were collected using a Yamshidi needle, guided by the image intensifier, with cylindrical shape and measuring approximately 6 mm long and 2 mm in diameter, the remaining six, under direct vision with the aid of a biopsy punch or curette. All were immediately immersed in the appropriate fixative during surgery and sent for further analysis according to protocol. In the pathology laboratory, the samples were fixed for 12 to 16 hours in 10% buffered formalin, with 10 times the volume of the sample. Sequentially, they were washed to remove excess fixative and transferred to a softener, which promoted the removal of calcium phosphate from the bone tissue, using 10% nitric acid (155 ml of 65% nitric acid and 845 ml distilled water) for approximately 24 hours. Afterwards, they were washed with distilled water for six hours to remove the acid and embedded in paraffin, melted at 60°C, to form blocks. Slides were then prepared from serial transverse sections, that were 200-μm on average, with a steel blade, and stained with hematoxylin-eosin (HE). During this process, the HE showed the LBG to be slightly bluish, not matching the areas of osteogenesis that are pink under microscopy ([Figures 1](#fig1){ref-type="fig"} and [2](#fig2){ref-type="fig"}). So, after scanning the images, the areas occupied by each compound can clearly be seen and measured. A doctor from the Pathology Clinic -- blinded to those cases -- was responsible for the histological analysis of the slides, discerning -- according to the doctor\'s own criteria -- the following findings: resorption of the graft, presence of signs of inflammation and/or infection (neutrophils), neoformation bone, and fibrosis. After this, a second group of researchers, independent and similarly blinded with respect to cases, digitized the slides and measured the mineralized areas occupied by the LBG and the newly formed bone. Micrographs were taken through a microscope (Axiolab E, Carl Zeiss, Gottingen, Germany) coupled with a high-definition camera (Sony Inc., Japan). The images were inserted into a graphics program (ImageJ 1.40 -- National Institutes of Health, USA, <http://rsb.info.nih.gov/ij/>) for accurate quantification of each area. Histomorphometric parameters were described as pixels by a semi-automatic analysis system; these data were transferred to Excel for Windows, which defined the proportions of each component within the total mineralized area.

Statistical analysis was performed using SPSS 13 for Windows (SPSS Inc. Chicago, IL, USA). Descriptive analyses are presented as mean, maximum, and minimum values for quantitative variables and percentage for qualitative variables.

All of the risks, benefits, and the purpose of the surgery and bone biopsies were made clear to the patients prior to the study, and each was required to sign an informed consent form agreeing with every phase. This study was conducted by the Hip Group of the Orthopedics and Traumatology Clinic, Department of Surgery, Hospital de Clínicas de Porto Alegre (HCPA), Universidade Federal do Rio Grande do Sul (UFRGS), in collaboration with the Pathology Clinic of the institution. This study was approved by the research and ethics committee of the graduate group (GPPG) of HCPA.

RESULTS {#cesec30}
=======

Global analysis {#cesec40}
---------------

All demographic data are shown in [Table 1](#tbl1){ref-type="table"}. The average age in the group was 51 years (24 to 82), consisting of four (34%) male and eight (66%) female patients. The average length of hospitalization was 10 (3-38) days and mean follow-up was 49 months (6-115).

Histological analysis {#cesec50}
---------------------

The slides showed a homogeneous histological pattern when examined microscopically by the pathologist according to their own criteria ([Table 2](#tbl2){ref-type="table"}). None of them showed an exacerbated inflammatory response in the periphery of the LBG, which rules out the chance of the body rejecting the foreign body. Neutrophils were only detected in the lamina of patient SG. The presence of varying amounts of fibrosis ([Figure 3](#fig3){ref-type="fig"}), signs of a partially resorbed graft ([Figure 4](#fig4){ref-type="fig"}), and osteogenesis ([Figure 5](#fig5){ref-type="fig"}) were evident in all samples. Avital bone tissue, corresponding to the LBG, which was stained in blue, and vitalized tissue (with nucleated cells) representing newly formed bone, were present in the slides analyzed. The integration between the original bone, the LBG, and the areas of new bone formation are microscopically well defined and occur in large blocks, but maintaining a clear boundary between each ([Figure 6](#fig6){ref-type="fig"}).

Specific analysis {#cesec60}
-----------------

The digitized slides showed a mean proportion of 42% (13-85%) of lyophilized bovine graft and 58% (15-87%) of new bone formation in relation to the total mineralized area ([Table 3](#tbl3){ref-type="table"}). Importantly, two patients showed significant differences in relation to the other samples with a ratio of LBG/bone formation of 85/15% and 76/24%, and the slides were reviewed, in order to exclude any measurement errors.

Radiographic analysis {#cesec70}
---------------------

The radiographs of all patients showed satisfactory consolidation in the perimeter of the graft.

DISCUSSION {#cesec80}
==========

The possibility of using lyophilized bovine graft (LBG) as an alternative to autologous graft in orthopedic surgery has been investigated for some time, particularly in animal models[@bib6]. This study contributes information that is extremely relevant to the use of LBG, produced according to the protocol developed by the main author, in humans, since it demonstrates its osseointegration. Previous studies endorse the use of this LBG both in animals[@bib15], [@bib16] and in humans[@bib2], [@bib5], [@bib18]. Meyer et al[@bib21] brought forth the first data relating to histological osseointegration in relation to LBG -- Tutobone^®^ -- in humans. These results were promising, prompting us to evaluate our biopsies and compare the results with those available in the literature.

In our study, which has a design similar to Meyer et al[@bib21], we found a proportion of 42% preservation of the LBG and 58% related to areas of new bone formation compared to the total mineralized area on the slides analyzed in an average period of 49 months. These data are very similar to those presented by this author, who reports having 47% preservation with Tutobone^®^ and 53% of new bone formation in the course of 11 months in nine samples.

The presence of LBG in the biopsies allows us to infer that the graft proposed presents undeniable osteoconductivity, being only partially reabsorbed in humans, unlike the complete remodeling which occurs in animals. We found no linear correlation between the duration of follow-up and proportions of LBG/bone formation in relation to the total mineralized area, and it was not possible to define an exact pattern of behavior, as the sample with nine months of follow-up had a higher rate of neoformed bone than at 62 months. The fact that the slide that had the highest rate of new bone formation (87%) was one of the longest durations of follow-up (82 months) is also relevant. Thus, we can say that the LBG used promotes satisfactory, efficient, and durable osseointegration, with human bone tissue during the follow-up period measured.

It is interesting to note that in two samples there were important differences in relation to the others, which were confirmed after further analysis: the LBG/osteogenesis ratio of 85/15% and 76/24%, showing less osteoblastic activity around the graft. There was less bone remodeling in these cases, suggesting some biological or mechanical limiting factor in bone repair. One has Albright syndrome with severe bone and metabolic impairment, which may be a factor related to reduced bone formation. Importantly, even these samples showed no difference in the rate of consolidation, or worse clinical outcomes.

This leads us to think that the type and quantity of graft applied are not solely responsible for the capacity for new local bone formation, but that every organism, with its different biological characteristics, affects the response of the osseointegration process. Elucidating this is not the purpose of the present study, but it could justify the behavior. The absence of a foreign body reaction in all slides demonstrates the biocompatibility of the lyophilized bovine graft developed by our group in this study.

The presence of satisfactory osseointegration in radiographic examinations shows that the LBG in this study presents a visual pattern similar to other commonly used types of grafts. Previous experiments showed full osseointegration in 75.8% after six months and nearly all cases at 12 months[@bib21].

We did not use a control group, since the study design did not allow for it. The objective of the study is to evaluate the histological behavior of LBG in humans and not to discuss its superiority.

CONCLUSION {#cesec90}
==========

This is the first histological study using lyophilized bovine graft (LBG), produced according to the protocol developed by the main author, in humans. The results show that this graft had satisfactory biocompatibility and did not harm the patients. Additionally, it showed good osteoconduction and integration in an average follow-up period of 49 months, fulfilling the role that was expected of it.

The results obtained are promising and contribute to strengthening the role of the LBG as a treatment option for dental and orthopedic surgeries that require some type of graft to fill bone defects.

Study conducted at the Hospital de Clínicas de Porto Alegre, Porto Alegre, RS.

![Lyophilized bovine graft (LBG) stained blue with hematoxylin-eosin (HE). 10x magnification. HCPA 2011.](gr1){#fig1}

![Blue areas denote the lyophilized bovine graft (LBG) stained with hematoxylin-eosin (HE). 100x magnification. HCPA 2011.](gr2){#fig2}

![Fibrosis represented by whitish light areas in the center of the image. 200x magnification. HCPA 2011.](gr3){#fig3}

![Lyophilized bovine graft (LBG) (blue areas) surrounded by newly formed bone tissue (pink areas). 200x magnification. HCPA 2011.](gr4){#fig4}

![Partially resorbed (blue areas) of lyophilized bovine graft (LBG) surrounded by newly formed bone tissue (pink areas). 200x magnification. HCPA 2011.](gr5){#fig5}

![Well-defined boundaries between the bluish lyophilized bovine graft (LBG) and the pink new bone. 400x magnification. HCPA 2011.](gr6){#fig6}

###### 

Demographic data.

  Patient   Sex   Age (years)   Procedure   Diagnosis                 Hospitalization (days)   Evolution (months)
  --------- ----- ------------- ----------- ------------------------- ------------------------ --------------------
  1         1     24            FO          Femoral pseudarthrosis    9                        6
                                                                                               
  2         1     25            TCA         Talocalcaneal arthrosis   3                        59
                                                                                               
  3         2     82            RTHA        Material wear and tear    10                       9
                                                                                               
  4         2     51            RTHA        Material wear and tear    9                        72
                                                                                               
  5         2     64            RTHA        Material wear and tear    10                       43
                                                                                               
  6         2     30            FO          Simple bone cyst          14                       68
                                                                                               
  7         2     79            RTHA        Material wear and tear    38                       19
                                                                                               
  8         2     55            THA         Coxarthrosis              7                        82
                                                                                               
  9         2     60            RTHA        Material wear and tear    12                       50
                                                                                               
  10        1     45            TO          Material wear and tear    3                        35
                                                                                               
  11        1     43            FO          Femoral pseudarthrosis    11                       16
                                                                                               
  12        1     48            RTHA        Material wear and tear    7                        115

1: Male, 2: Female; TO: Tibial osteosynthesis, FO: Femoral osteosynthesis, EBC: Excision of bone callus, TCA: Talocalcaneal arthrodesis, THA: Total hip arthroplasty, RTHA: revision of THA. HCPA 2011

###### 

Histological analysis of slides.

           Neutrophils   Fibrosis   LBG absorption   New local bone formation
  -------- ------------- ---------- ---------------- --------------------------
  ALL      −             \+         \+               \+
                                                     
  JARS 1   −             \+         \+               \+
                                                     
  JARS 2   −             \+         \+               \+
                                                     
  MTRC     −             \+         −                \+
                                                     
  EG       −             \+         \+               \+
                                                     
  AMB      −             \+         \+               \+
                                                     
  TGG      −             \+         \+               \+
                                                     
  AACS     −             \+         \+               \+
                                                     
  MB       −             \+         \+               \+
                                                     
  SG       \+            \+         \+               −
                                                     
  MH       −             \+         \+               \+
                                                     
  HJCS     −             \+         \+               \+
                                                     
  MAR      −             \+         \+               \+

+: present, -: absent. HCPA 2011

###### 

Proportions measured.

           LBG   Neoformation   Follow-up[\*](#tbl38fn1){ref-type="table-fn"}
  -------- ----- -------------- -----------------------------------------------
  ALL      37%   63%            6
                                
  JARS 1   34%   66%            59
                                
  JARS 2   34%   66%            59
                                
  MTRC     23%   77%            9
                                
  EG       32%   68%            72
                                
  AMB      60%   40%            43
                                
  TGG      85%   15%            68
                                
  AACA     26%   74%            19
                                
  MB       13%   87%            82
                                
  SG       76%   24%            50
                                
  MH       47%   53%            62
                                
  HJCS     38%   62%            16
                                
  MAR      39%   61%            115

months
